Nepal | May 27, 2020

Gastritis patients at high risk of cholera

Himalayan News Service
Share Now:

Kathmandu, June 26

Gastritis patients are at high risk of cholera, according to doctors.

According to coordinator of clinical research unit at Sukraraj Tropical and Infectious Disease Hospital, Dr Sher Bahadur Pun, patients taking medicines for gastritis are at high risk of being infected by Vibrio cholerae bacteria.

A 36-year- old patient from Kalimati was the first person admitted at the hospital for treatment of cholera this year. Dr Pun said he was on medication for gastritis for the last one month. “Acid inside our body help fight bacteria, so people taking medicine for gastritis easily get infected with Vibrio cholerae,” he said.

If not treated, cholera can lead to severe dehydration, unconsciousness or even death.


A version of this article appears in print on June 27, 2018 of The Himalayan Times.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Armyworm severely affects maize production

Kathmandu, May 25 The American armyworm has severely affected maize farming across the country this year as compared to previous year, hitting farmers who have already had to bear the brunt of the coronavirus pandemic. According to Centre for Crop Development and Agro Bio-Diversity Conservatio Read More...

Budget expectations

The government is all set to announce the budget for next fiscal year on Thursday and people involved in different sectors have various expectations. Amid this, The Himalayan Times spoke to a few tourism entrepreneurs who were not satisfied with the government’s policies and programmes to learn ab Read More...

Over 10,000 Nepalis enter country from Jamunaha border point in four days

NEPALGUNJ: Over 10,000 Nepalis have entered the country from Jamunaha border point in Banke district amid nationwide lockdown imposed by the government to curb the spread of COVID-19. A large number of migrant workers returning from India have been gathering at the border point with the easing of Read More...

UN virus therapy trial pauses hydroxychloroquine testing

GENEVA: The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug US President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date. Read More...

PMEP to be promoted as major source of employment next fiscal

Kathmandu, May 25 The government is preparing to promote the Prime Minister Employment Programme (PMEP) as the major source of employment for those who have lost or will lose their jobs due to the COVID-19 and for returnee migrant workers through the budget for the next fiscal year. The Minist Read More...

NRB directs BFIs to categorise banknotes based on quality

Kathmandu, May 25 Nepal Rastra Bank (NRB) has directed banks and financial institutions (BFIs) to categorise banknotes based on their quality — new, clean and useless. Issuing a nine-point circular on Sunday, the central bank directed BFIs to categorise banknotes accordingly and maintain the Read More...

Trump honours war dead in events coloured by pandemic's threat

BALTIMORE: President Donald Trump honoured America’s war dead Monday in back-to-back Memorial Day appearances coloured by an epic struggle off the battlefield, against the coronavirus. Eager to demonstrate national revival from the pandemic, Trump doubled up on his public schedule, while threa Read More...

Jimmy Cobb, 'Kind of Blue' drummer for Miles Davis, dies

Jimmy Cobb, a percussionist and the last surviving member of Miles Davis’ 1959 “Kind of Blue” groundbreaking jazz album which transformed the genre and sparked several careers, died Sunday. His wife, Eleana Tee Cobb, announced on Facebook that her husband died at his New York City home from Read More...